AMRN
Price
$16.73
Change
+$0.08 (+0.48%)
Updated
Jul 3 closing price
Capitalization
357.53M
24 days until earnings call
GIFLF
Price
$11.45
Change
-$0.85 (-6.91%)
Updated
Jun 23 closing price
Capitalization
8.78B
Interact to see
Advertisement

AMRN vs GIFLF

Header iconAMRN vs GIFLF Comparison
Open Charts AMRN vs GIFLFBanner chart's image
Amarin
Price$16.73
Change+$0.08 (+0.48%)
Volume$83.67K
Capitalization357.53M
Grifols Sa
Price$11.45
Change-$0.85 (-6.91%)
Volume$1.22K
Capitalization8.78B
AMRN vs GIFLF Comparison Chart in %
Loading...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GIFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRN vs. GIFLF commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRN is a Hold and GIFLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (AMRN: $16.73 vs. GIFLF: $11.45)
Brand notoriety: AMRN: Notable vs. GIFLF: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AMRN: 67% vs. GIFLF: 95%
Market capitalization -- AMRN: $357.53M vs. GIFLF: $8.78B
AMRN [@Pharmaceuticals: Major] is valued at $357.53M. GIFLF’s [@Pharmaceuticals: Major] market capitalization is $8.78B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRN’s FA Score shows that 0 FA rating(s) are green whileGIFLF’s FA Score has 1 green FA rating(s).

  • AMRN’s FA Score: 0 green, 5 red.
  • GIFLF’s FA Score: 1 green, 4 red.
According to our system of comparison, GIFLF is a better buy in the long-term than AMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRN’s TA Score shows that 5 TA indicator(s) are bullish while GIFLF’s TA Score has 4 bullish TA indicator(s).

  • AMRN’s TA Score: 5 bullish, 4 bearish.
  • GIFLF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, AMRN is a better buy in the short-term than GIFLF.

Price Growth

AMRN (@Pharmaceuticals: Major) experienced а +5.22% price change this week, while GIFLF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.13%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Reported Earning Dates

AMRN is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.13% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GIFLF($8.79B) has a higher market cap than AMRN($358M). AMRN has higher P/E ratio than GIFLF: AMRN (67.11) vs GIFLF (62.50). AMRN YTD gains are higher at: 72.474 vs. GIFLF (19.895). GIFLF has higher annual earnings (EBITDA): 726M vs. AMRN (-50.7M). GIFLF has more cash in the bank: 557M vs. AMRN (321M). AMRN has less debt than GIFLF: AMRN (8.74M) vs GIFLF (10.9B). GIFLF has higher revenues than AMRN: GIFLF (6.46B) vs AMRN (307M).
AMRNGIFLFAMRN / GIFLF
Capitalization358M8.79B4%
EBITDA-50.7M726M-7%
Gain YTD72.47419.895364%
P/E Ratio67.1162.50107%
Revenue307M6.46B5%
Total Cash321M557M58%
Total Debt8.74M10.9B0%
FUNDAMENTALS RATINGS
AMRN vs GIFLF: Fundamental Ratings
AMRN
GIFLF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
19
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9386
PRICE GROWTH RATING
1..100
3646
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GIFLF's Valuation (19) in the null industry is significantly better than the same rating for AMRN (87) in the Pharmaceuticals Other industry. This means that GIFLF’s stock grew significantly faster than AMRN’s over the last 12 months.

GIFLF's Profit vs Risk Rating (100) in the null industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that GIFLF’s stock grew similarly to AMRN’s over the last 12 months.

GIFLF's SMR Rating (86) in the null industry is in the same range as AMRN (93) in the Pharmaceuticals Other industry. This means that GIFLF’s stock grew similarly to AMRN’s over the last 12 months.

AMRN's Price Growth Rating (36) in the Pharmaceuticals Other industry is in the same range as GIFLF (46) in the null industry. This means that AMRN’s stock grew similarly to GIFLF’s over the last 12 months.

GIFLF's P/E Growth Rating (97) in the null industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that GIFLF’s stock grew similarly to AMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRNGIFLF
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
58%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
47%
Momentum
ODDS (%)
Bullish Trend 4 days ago
78%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
43%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
40%
Advances
ODDS (%)
Bullish Trend 6 days ago
73%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
68%
Aroon
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
26%
View a ticker or compare two or three
Interact to see
Advertisement
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GIFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SIXF29.860.17
+0.58%
AllianzIM US Lrg Cp 6M Bfr10 Feb/Aug ETF
BSMC32.460.14
+0.44%
Brandes U.S. Small-Mid Cap Value ETF
GQRE60.220.01
+0.01%
FlexShares Glbl Quality Real Estate ETF
JIII50.59-0.02
-0.04%
Janus Henderson Income ETF
KYN12.61-0.03
-0.24%
Kayne Anderson Energy Infrastructure Fund

GIFLF and

Correlation & Price change

A.I.dvisor tells us that GIFLF and GIFOF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GIFLF and GIFOF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GIFLF
1D Price
Change %
GIFLF100%
N/A
GIFOF - GIFLF
32%
Poorly correlated
N/A
GIKLY - GIFLF
27%
Poorly correlated
N/A
GRFS - GIFLF
22%
Poorly correlated
-0.66%
AMRN - GIFLF
21%
Poorly correlated
+0.48%
BAYZF - GIFLF
6%
Poorly correlated
-0.90%
More